Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia.

Clinical lymphoma, myeloma & leukemia - 1 May 2021

Phoompoung Pakpoom, Henry Benoît, Daher-Reyes Georgina, Sibai Hassan, Husain Shahid

Abstract excerpt

BACKGROUND: The incidence and risk factors for invasive mold infections (IMI) in acute myeloid leukemia (AML) patients carrying FLT3 mutations have not been addressed. PATIENTS AND METHODS: This retrospective cohort included FLT3-mutated AML patients (2008-2018). Primary outcome was IMI incidence within 6 months after first induction or salvage therapy. RESULTS: We included 108 patients receiving fluconazole or...

Topics

Adult
Aged
Aged, 80 and over
Female
Humans
Invasive Fungal Infections
Leukemia, Myeloid, Acute
Male
Middle Aged
Mutation
Retrospective Studies
Young Adult

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

fms-Like Tyrosine Kinase 3

Source

Identifiers

PMID: 33678591
DOI: 10.1016/j.clml.2020.10.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-33678591-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia.PMID 33678591Read ↗

Isavuconazole therapy in an FLT3 mutated acute myeloid leukemia patient receiving midostaurin: A case report.Semantic proximity Read ↗

Gilteritinib: The Story of a Proceeding Success into Hard-to-Treat FLT3 Mutated AML PatientsSemantic proximity Read ↗

Midostaurin in acute myeloid leukemia: current evidence and practical considerations in routine clinical use.Semantic proximity Read ↗

Breakthrough Mucormycosis After Hematopoietic Stem Cell Transplantation: A Retrospective Multiyear Cohort Study in Eastern ChinaSemantic proximity Read ↗

Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study.Semantic proximity Read ↗

Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin.Semantic proximity Read ↗

Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy.Semantic proximity Read ↗

Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.Semantic proximity Read ↗

Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency.Semantic proximity Read ↗

Dermatological toxicity associated with the use of gilteritinib in relapsed acute myeloid leukemia with FLT3 mutation: a case report.Semantic proximity Read ↗

Evaluation of drug-drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML).Semantic proximity Read ↗

Diagnosis of invasive mold diseases in patients with hematological malignancies using <i>Aspergillus</i>,<i> Mucorales,</i> and panfungal <scp>PCR</scp> in <scp>BAL</scp>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.